Description
The p.V2016M variant (also known as c.6046G>A), located in coding exon 27 of the SCN5A gene, results from a G to A substitution at nucleotide position 6046. The valine at codon 2016 is replaced by methionine, an amino acid with highly similar properties. This alteration has been detected in individuals with long QT syndrome (LQT), Brugada syndrome (BrS), arrhythmogenic right ventricular cardiomyopathy (ARVC), sudden death, hypertrophic cardiomyopathy (HCM), and dilated cardiomyopathy (HCM); however, clinical details were often limited and co-occurring variants were reported in some cases (Shy D et al. Circulation, 2014 Jul;130:147-60; Chen J et al. Heart Rhythm, 2016 Jan;13:289-98; Christiansen SL et al. Eur J Hum Genet, 2016 12;24:1797-1802; Te Riele AS et al. Cardiovasc Res, 2017 01;113:102-111; Hayashi T et al. J Hum Genet, 2018 Sep;63:989-996; van Lint FHM et al. Neth Heart J, 2019 Jun;27:304-309). Studies of the effect of this variant on channel function were contradictory, with both gain and loss of function reported by different investigators (Shy D et al. Circulation, 2014 Jul;130:147-60; Chen J et al. Heart Rhythm, 2016 Jan;13:289-98). This variant has also been reported in an ostensibly healthy cohort (Bajaj A et al. Hum Genomics, 2022 Aug;16:30). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | germline | unknown | not provided | not provided | not provided | | not provided | not provided | not provided | not provided |